We have developed a variety of tools and methods that accelerate the discovery of small molecule drugs based on the principles of molecular recognition between therapeutic agents and protein targets. Our methods enable high accuracy and speed in the assessment of molecular properties and their tendency to bind therapeutic targets. By accessing our proprietary technologies, customers are then able to focus their research on their most promising leads and experience considerable enhancement of research efficiency.